Cellzome logo — company profile

Cellzome

Founded 2000 36 employees Grant Total: $65.95M Biotechnology, Health and Wellness +1

General Information

Company Name Cellzome
Founded Year 2000
Employees 36
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Cellzome. To contact Cellzome, visit cellzome.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cellzome compare?

A PDF of Cellzome and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cellzome soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cellzome

Cellzome is a privately-owned drug discovery company founded in 2000. The company specializes in identifying a new generation of kinase-targeted drugs to treat inflammatory diseases. Their pipeline of small-molecule therapeutics is driven by Kinobeads™, a proprietary technology for the screening and profiling of kinases in relevant cells and tissues. Cellzome is applying its distinctive Kinobeads™ technology to the discovery and development of novel, selective kinase inhibitors targeting key inflammatory mediators in immune receptor signaling and chemotaxis, including PI3Kγ and Zap-70. The company received a €3.85M grant investment on 25 November 2008. The investment came at a crucial time, providing the necessary funding for their innovative drug discovery efforts. Cellzome operates within the industries of Biotechnology, Health and Wellness, and Pharmaceutical, and their groundbreaking work in identifying potential treatments for inflammatory diseases positions them as an intriguing prospect for potential investors in the biotech and pharmaceutical sectors.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €3.85M -
25 Nov 2008
Grant €1.10M 1
German Federal Ministry of Education and Research
12 Oct 2005
Series C €30.00M 5
Advent International, Atlas Venture +3
17 Mar 2003
Series B $31.00M 4
Index Ventures, Advent International +2
01 Mar 2001

Cellzome Alternatives & Competitors

View All Alternatives
Cellzome vs

Opsona Therapeutics is a leading drug development company specialising in the human immune system....

Series C
8 employees
Biotechnology, Health Care
Cellzome vs

We are committed to developing transformational biologic medicines to serve patients with debilitati...

Post-IPO Equity
17 employees
Biotechnology, Health and Wellness
Cellzome vs

Harnessing the power of hydroxyl dendrimers to create a new class of disease cell-targeted precision...

Series B
24 employees
Biotechnology, Health Care

FAQ About Cellzome

Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads™, a proprietary technology for the screening and profiling of kinases in relevant cells and t...
Cellzome was founded in 2000.
Cellzome operates in Biotechnology, Health and Wellness and Pharmaceutical.
Cellzome has approximately 36 employees.
Cellzome has completed 4 funding rounds, raising a total of $65.95M. The latest funding stage is Grant.
Top alternatives and competitors to Cellzome include Opsona Therapeutics, Applied Molecular Transport, Ashvattha Therapeutics, Inc., InflaRx, ImmunoBiochem Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellzome and Opsona Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cellzome, https://bouncewatch.com/company/cellzome, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes